Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Desensitisation of ulcerative colitis patients intolerant to mesalazine
2010-018557-35Phase 4Active
- Sponsor
- University Medical Center Groningen
- Start
- Feb 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Salcrozine in autoimmune colitis, sponsored by University Medical Center Groningen. Primary endpoints: Successful desensitisation for mesalazine and Reproducibility of presumed mesalazine intolerance. Started Feb 2010; status: active.
02
Drugs
Salcrozine
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on 2010-018557-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-018557-35.